BTC Health has announced that its wholly-owned investee company, BTC Pharma, has amended its existing License & Distribution Agreement for the Bronchitol & Aridol products & extended its partnership with Arna Pharma, with effect from 1 February 2025 | btchealth.com.au/wp-content/upl…

BTC Health has appointed Salesh Balak as its CFO & Company Secretary, the appointment reflects the underlying expansion of the BTC business, & will be accompanied by the appointment of Josh Kahanovitz, current Head of Finance, to the role of COO | btchealth.com.au/wp-content/upl…

BTC Health (ASX: BTC) has announced its half-year financial results for the 6 months ending 31 December 2024, along with a general business update. ASX announcement: btchealth.com.au/wp-content/upl… Investor presentation: btchealth.com.au/wp-content/upl…